CCR2B receptor antagonists: conversion of a weak HTS hit to a potent lead compound.
Forbes IT, Cooper DG, Dodds EK, Hickey DM, Ife RJ, Meeson M, Stockley M, Berkhout TA, Gohil J, Groot PH, Moores K.
Forbes IT, et al. Among authors: berkhout ta.
Bioorg Med Chem Lett. 2000 Aug 21;10(16):1803-6. doi: 10.1016/s0960-894x(00)00347-4.
Bioorg Med Chem Lett. 2000.
PMID: 10969972